The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Severe CD4+T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy
Open accessAbstract
Gut-associated lymphoid tissue (GALT) harbors the majority of T lymphocytes in the body and is an important target for human immunodeficiency virus type 1 (HIV-1). We analyzed longitudinal jejunal biopsy samples from HIV-1-infected patients, during both primary and chronic stages of HIV-1 infection, prior to and following the initiation of highly active antiretroviral therapy (HAART) to determine the onset of CD4+T-cell depletion and the effect of HAART on the restoration of CD4+T cells in GALT. Severe depletion of intestinal CD4+T cells occurred during primary HIV-1 infection. Our results showed that the restoration of intestinal CD4+T cells following HAART in chronically HIV-1-infected patients was substantially delayed and incomplete. In contrast, initiation of HAART during early stages of infection resulted in near-complete restoration of intestinal CD4+T cells, despite the delay in comparison to peripheral blood CD4+T-cell recovery. DNA microarray analysis of gene expression profiles and flow-cytometric analysis of lymphocyte homing and cell proliferation markers demonstrated that cell trafficking to GALT and not local proliferation contributed to CD4+T-cell restoration. Evaluation of jejunal biopsy samples from long-term HIV-1-infected nonprogressors showed maintenance of normal CD4+T-cell levels in both GALT and peripheral blood. Our results demonstrate that near-complete restoration of mucosal immune system can be achieved by initiating HAART early in HIV-1 infection. Monitoring of the restoration and/or maintenance of CD4+T cells in GALT provides a more accurate assessment of the efficacy of antiviral host immune responses as well as HAART.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In these blood cell preparations, organ-specific non-peripheral cells with tissue-homing markers can also transiently appear. 16-20”
From Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods (2023) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is known that especially integrin a 4 b 7 -expressing cells are predominantly infected and depleted during the early infection phases, with a rather poor recovery during ART. 18,20”
From Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods (2023) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., & Walker, B. D. (1997) · Science · doi:10.1126/science.278.5342.1447 · Cited by 1,832
Autran, B., Carcelain, G., Li, T., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debré, P., & Leibowitch, J. (1997) · Science · doi:10.1126/science.277.5322.112 · Cited by 1,786
Veazey, R. S., DeMaria, M. A., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,404
Immune control of HIV-1 after early treatment of acute infection
Rosenberg, E. S., Altfeld, M. A., Poon, S. H. T., Phillips, M. N., Wilkes, B. M., Eldridge, R. L., Robbins, G. K., D’Aquila, R. T., Goulder, P., & Walker, B. D. (2000) · Nature · doi:10.1038/35035103 · Cited by 1,002
Programmed Death of T Cells in HIV-1 Infection
Meyaard, L., Otto, S. A., Jonker, R. R., Mijnster, M. J., Keet, R., & Miedema, F. F. (1992) · Science · doi:10.1126/science.1352911 · Cited by 898
Haase, A. T. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.625 · Cited by 541
Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis
Ameisen, J. C., & Capron, A. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90092-8 · Cited by 527
Zhao, H., Watkins, J. L., & Piwnica-Worms, H. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182557299 · Cited by 472
Lederman, M. M., Connick, E., LANDAY, A. L., Kuritzkes, D. R., Spritzler, J., Clair, M. S., Kotzin, B. L., Fox, L. L., Heath-Chiozzi, M. E., Leonard, J. M., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/515591 · Cited by 425
Overview of the Mucosal Immune System
Brandtzaeg, P. (1989) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-74529-4_2 · Cited by 274
Cited by
Sorted by citations
Items 401–500 of 867
Moore, A. C., Bixler, S. L., Lewis, M. G., Verthelyi, D. I., & Mattapallil, J. J. (2011) · Journal of Virology · doi:10.1128/jvi.06372-11 · Cited by 27
Potential Implication of Residual Viremia in Patients on Effective Antiretroviral Therapy
Sahu, G. K. (2014) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0194 · Cited by 28
Isolating Mucosal Lymphocytes from Biopsy Tissue for Cellular Immunology Assays
Shacklett, B. L., Critchfield, J. W., & Lemongello, D. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-170-3_23 · Cited by 28
Kim, C. J., Rousseau, R. K., Huibner, S., Kovacs, C. M., Benko, E., Shahabi, K., Kandel, G. P., Ostrowski, M., & Kaul, R. (2017) · AIDS · doi:10.1097/qad.0000000000001515 · Cited by 28
Probing the sequence space available for HIV-1 evolution
ter Brake, O., von Eije, K. J., & Berkhout, B. (2008) · AIDS · doi:10.1097/qad.0b013e328309efe3 · Cited by 28
Molecular Analyses Define Vα7.2-Jα33+ MAIT Cell Depletion in HIV Infection
Ussher, J. E., Phalora, P. K., Cosgrove, C., Hannaway, R. F., Rauch, A., Günthard, H. F., Goulder, P., Phillips, R. E., Willberg, C. B., & Klenerman, P. (2015) · Medicine · doi:10.1097/md.0000000000001134 · Cited by 28
Ries, M., Pritschet, K., & Schmidt, B. (2011) · Clinical and Developmental Immunology · doi:10.1155/2012/534929 · Cited by 29
Kader, M., Bixler, S. L., Piatak, M., Lifson, J. D., & Mattapallil, J. J. (2009) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2009.00373.x · Cited by 27
Use of predictive markers of HIV disease progression in vaccine trials
Gurunathan, S., Habib, R. E., Baglyos, L., Méric, C., Plotkin, S. A., Dodet, B., Corey, L., & TARTAGLIA, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.039 · Cited by 28
Kelleher, A. D., & Zaunders, J. J. (2006) · Current HIV/AIDS Reports · doi:10.1007/s11904-006-0002-5 · Cited by 27
Timmons, T., Shen, C., Aldrovandi, G. M., Rollie, A., Gupta, S. K., Stein, J. H., & Dubé, M. P. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0162 · Cited by 27
Zhao, X., Zhang, M., Li, Z., & Frankel, F. R. (2006) · Journal of Virology · doi:10.1128/jvi.00894-06 · Cited by 27
Sonic Hedgehog mimetic prevents leukocyte infiltration into the CNS during acute HIV infection
Singh, V. B., Singh, M. V., Piekna‐Przybylska, D., Gorantla, S., Poluektova, L. Y., & Maggirwar, S. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-10241-0 · Cited by 27
Mfunyi, C. M., Vaillancourt, M., Vitry, J., Batomene, T.-R. N., Posvandzic, A., Lambert, A. A., & Gilbert, C. (2015) · Virology · doi:10.1016/j.virol.2015.05.013 · Cited by 28
Mela, C. M., Steel, A., Lindsay, J. O., Gazzard, B., Gotch, F. M., & Goodier, M. R. (2007) · AIDS · doi:10.1097/qad.0b013e3282f08b72 · Cited by 27
Mehandru, S., & Deren, S. (2015) · Journal of Addiction Research & Therapy · doi:10.4172/2155-6105.1000257 · Cited by 26
Preliminary in vivo efficacy studies of a recombinant rhesus anti-α4β7 monoclonal antibody
Pereira, L. E., Onlamoon, N., Wang, X., Wang, R., Li, J., Reimann, K. A., Villinger, F. J., Pattanapanyasat, K., Mori, K., & Ansari, A. A. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.06.012 · Cited by 26
Pilakka‐Kanthikeel, S., Kris, A., Selvaraj, A., Swaminathan, S., & Pahwa, S. G. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000096 · Cited by 26
Nair, S., Bayer, W., Ploquin, M. J.-Y., Kassiotis, G., Hasenkrug, K. J., & Dittmer, U. (2011) · Retrovirology · doi:10.1186/1742-4690-8-76 · Cited by 27
George, M. D., Verhoeven, D. E., McBride, Z., & Dandekar, S. (2006) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2006.00180.x · Cited by 26
Self-citationBelisle, S. E., Yin, J., Shedlock, D. J., Dai, A., Yan, J., Hirao, L. A., Kutzler, M. A., Lewis, M. G., Andersen, H., Lank, S. M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019681 · Cited by 26
Cunha, M. D. P., Vilela, A. P. P., Molina, C. V., Acuña, S. M., Muxel, S. M., Barroso, V. D. M., Baroni, S., de Oliveira, L. G., Angelo, Y. D. S., Peron, J. P. S., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.760170 · Cited by 24
Mwimanzi, P., Markle, T. J., Ueno, T., & Brockman, M. A. (2012) · Viruses · doi:10.3390/v4091711 · Cited by 25
Boulware, D. R., Meya, D. B., Bergemann, T. L., Williams, D. A., Louis, I. V.-S., Rhein, J., Staddon, J. H., Kambugu, A., Janoff, E. N., & Bohjanen, P. R. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181ef4963 · Cited by 25
Ruane, D., Do, Y., Brane, L., Garg, A., Bozzacco, L., Kraus, T., Caskey, M. F., Salazar, A. Μ., Trumpheller, C., & Mehandru, S. (2016) · Mucosal Immunology · doi:10.1038/mi.2015.133 · Cited by 25
Briz, V., Poveda, E., González, M. D. M., Martín‐Carbonero, L., González, R., & Soriano, V. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm469 · Cited by 25
Rueda, C. M., Velilla, P. A., Chougnet, C. A., & Rugeles, M. T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071062 · Cited by 24
Russo, E., Nannini, G., Sterrantino, G., Kiros, S. T., Pilato, V. D., Coppi, M., Baldi, S., Niccolai, E., Ricci, F., Ramazzotti, M., et al. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i6.635 · Cited by 26
SARS-CoV-2 immunity and vaccine strategies in people with HIV
Mullender, C., da Costa, K., Alrubayyi, A., Pett, S. L., & Peppa, D. (2022) · Oxford Open Immunology · doi:10.1093/oxfimm/iqac005 · Cited by 23
Chono, H., Saito, N., Tsuda, H., Shibata, H., Ageyama, N., Terao, K., Yasutomi, Y., Mineno, J., & Kato, I. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023585 · Cited by 24
Heterogeneous Memory T Cells in Antiviral Immunity and Immunopathology
Verhoeven, D. E., Teijaro, J. R., & Färber, D. L. (2008) · Viral Immunology · doi:10.1089/vim.2007.0002 · Cited by 29
Cassol, E., Rossouw, T. M., Malfeld, S., Mahasha, P. W., Slavík, T., Seebregts, C. J., Bond, R. P., du Plessis, J., Janssen, C., Roskams, T., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1176-5 · Cited by 24
Cimini, E., Agrati, C., D’Offizi, G., Vlassi, C., Casetti, R., Sacchi, A., Lionetti, R., Bordoni, V., Tumino, N., Scognamiglio, P., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129771 · Cited by 24
Differentiating Immune Cell Targets in Gut-Associated Lymphoid Tissue for HIV Cure
Khan, S., Telwatte, S., Trapečar, M., Yukl, S. A., & Sanjabi, S. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2017.0153 · Cited by 27
Human T cell reconstitution in DiGeorge syndrome and HIV-1 infection
Hudson, L. L., Markert, M. L., Devlin, B. H., Haynes, B. F., & Sempowski, G. D. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2007.10.002 · Cited by 24
The aftermath of the Merck's HIV vaccine trial
Iaccino, E., Schiavone, M., Fiume, G., Quinto, I., & Scala, G. (2008) · Retrovirology · doi:10.1186/1742-4690-5-56 · Cited by 24
Asowata, O. E., Singh, A., Ngoepe, A., Herbert, N. G., Fardoos, R., Reddy, K., Zungu, Y., Nene, F., Mthabela, N., Ramjit, D., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.146162 · Cited by 22
Liu, X., Lin, L., Lu, L., Li, X., Han, Y., Qiu, Z., Li, X., Li, Y., Song, X., Cao, W., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.807890 · Cited by 23
Sui, Y., Gagnon, S. J., Dzutsev, A. H., Zhu, Q., Yu, H., Hogg, A. E., Wang, Y., Xia, Z., Belyakov, I. M., Venzon, D. J., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.10.043 · Cited by 23
Endotoxin in the gut and chylomicrons: translocation or transportation?
Grünfeld, C., & Feingold, K. R. (2008) · Journal of Lipid Research · doi:10.1194/jlr.e800018-jlr200 · Cited by 23
Nyström, J., Stenkvist, J., Häggblom, A., Weiland, O., & Nowak, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118643 · Cited by 24
Breed, M. W., Elser, S. E., Torben, W., Jordan, A. P. O., Aye, P. P., Midkiff, C. C., Schiro, F. R., Sugimoto, C., Alvarez-Hernandez, X., Blair, R. V., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01134-15 · Cited by 23
van Marle, G., Church, D. L., Nunweiler, K. D., Cannon, K., Wainberg, M. A., & Gill, M. J. (2010) · Retrovirology · doi:10.1186/1742-4690-7-74 · Cited by 23
Lu, X., Li, Z., Li, Q., Jiao, Y., Ji, Y., Zhang, H., Liu, Z., Li, W., & Wu, H. (2015) · Cellular and Molecular Immunology · doi:10.1038/cmi.2015.60 · Cited by 22
Sellier, P., Mannioui, A., Bourry, O., Dereuddre‐Bosquet, N., Delache, B., Brochard, P., Calvo, J., Prevot, S., & Roques, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010570 · Cited by 22
Stable CD4 Expression and Local Immune Activation in the Ectocervical Mucosa of HIV-Infected Women
Hirbod, T., Kimani, J., Tjernlund, A., Cheruiyot, J., Petrova, A., Ball, T. B., Mugo, N., Jaoko, W. G., Plummer, F. A., Kaul, R., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301220 · Cited by 22
Yin, L., Kou, Z. C., Rodriguez, C. A., Hou, W., Goodenow, M. M., & Sleasman, J. W. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00074-09 · Cited by 22
Cassol, E., Malfeld, S., Mahasha, P. W., Bond, R. P., Slavík, T., Seebregts, C. J., Poli, G., Cassol, S. A., der Merwe, V., & Rossouw, T. M. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit249 · Cited by 22
Core-shell nanoparticles for targeted and combination antiretroviral activity in gut-homing T cells
Cao, S., Jiang, Y., Zhang, H., Kondza, N., & Woodrow, K. A. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.06.005 · Cited by 22
Imaging lymphoid tissues in nonhuman primates to understand SIV pathogenesis and persistence
Deléage, C., Türkbey, B., & Estes, J. D. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.07.002 · Cited by 21
Naidoo, K. K., Ndumnego, O. C., Ismail, N., Dong, K. L., & Ndung’u, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.738743 · Cited by 21
Littlefield, K. M., Schneider, J. M., Neff, C. P., Soesanto, V., Siebert, J., Nusbacher, N. M., Moreno-Huizar, N., Cartwright, I. M., Armstrong, A. J. S., Colgen, S. P., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1072720 · Cited by 22
Predictors of Poor CD4 and Weight Recovery in HIV-Infected Children Initiating ART in South Africa
Zanoni, B. C., Phungula, T., Zanoni, H. M., France, H., Cook, E. F., & Feeney, M. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033611 · Cited by 21
HIV’s Nef Interacts with β-Catenin of the Wnt Signaling Pathway in HEK293 Cells
Weiser, K., Barton, M., Gershoony, D., DasGupta, R., & Cardozo, T. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077865 · Cited by 21
Morrow, M. P., Tebas, P., Yan, J., Ramirez, L., Slager, A. M., Kraynyak, K. A., Diehl, M. C., Shah, D., Khan, A. S., Lee, J., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.245 · Cited by 21
Patro, S. C., Pal, S., Bi, Y., Lynn, K., Mounzer, K., Kostman, J. R., Davuluri, R. V., & Montaner, L. J. (2014) · Journal of Virology · doi:10.1128/jvi.02382-14 · Cited by 20
Shanmugasundaram, U., Kovářová, M., Ho, P. T., Schramm, N. J., Wahl, A. R., Parniak, M. A., & García, J. V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0159517 · Cited by 21
Nagy, L. H., Grishina, I., Macal, M., Hirao, L. A., Hu, W. K., Sankaran‐Walters, S., Gaulke, C. A., Pollard, R. B., Brown, J., Suni, M. A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072789 · Cited by 21
Self-citationEarly Treatment and HIV-1 Reservoirs: A Stitch in Time?
Henrich, T. J., & Gandhi, R. T. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit307 · Cited by 21
Clinical studies with chemokine receptor-5 (CCR5)-inhibitors
Boesecke, C., & Pett, S. L. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e328356e933 · Cited by 20
Manrique, M. L., Kozlowski, P. A., Cobo-Molinos, A., Wang, S.-W., Wilson, R. L., Montefiori, D. C., Carville, A., & Aldovini, A. (2013) · Journal of Virology · doi:10.1128/jvi.03531-12 · Cited by 20
Manrique, M. L., Kozlowski, P. A., Cobo-Molinos, A., Wang, S.-W., Wilson, R. L., Viedma, M. D. P. M., Montefiori, D. C., Carville, A., & Aldovini, A. (2013) · Journal of Virology · doi:10.1128/jvi.02523-13 · Cited by 20
Short Conserved Sequences of HIV-1 Are Highly Immunogenic and Shift Immunodominance
Yang, O. O., Ali, A., Kasahara, N., Faure-Kumar, E., Bae, J. Y., Picker, L. J., & Park, H. (2014) · Journal of Virology · doi:10.1128/jvi.02370-14 · Cited by 20
Old World Monkeys and New Age Science: The Evolution of Nonhuman Primate Systems Virology
Palermo, R. E., Tisoncik-Go, J., Korth, M. J., & Katze, M. G. (2013) · ILAR Journal · doi:10.1093/ilar/ilt039 · Cited by 20
Chan, M. L., Petravic, J., Ortiz, A. M., Engram, J. C., Paiardini, M., Cromer, D., Silvestri, G., & Davenport, M. P. (2010) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2010.0972 · Cited by 20
Mak, G., Zaunders, J. J., Bailey, M., Seddiki, N., Rogers, G. B., Leong, L. E. X., Phan, T. G., Kelleher, A. D., Koelsch, K. K., Boyd, M. A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.688886 · Cited by 20
Estes, J. D. (2009) · Current HIV/AIDS Reports · doi:10.1007/s11904-009-0005-0 · Cited by 20
Impact of γ‐chain cytokines on T cell homeostasis in HIV‐1 infection: therapeutic implications
Gougeon, M., & Chiodi, F. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02221.x · Cited by 23
The use of BLT humanized mice to investigate the immune reconstitution of the gastrointestinal tract
Wahl, A. R., & García, J. V. (2014) · Journal of Immunological Methods · doi:10.1016/j.jim.2014.06.009 · Cited by 20
Taylor, J. M., Ziman, M. E., Fong, J. M., Solnick, J. V., & Vajdy, M. (2007) · Infection and Immunity · doi:10.1128/iai.01470-06 · Cited by 20
Leeansyah, E., Zhou, J., Paukovics, G., Lewin, S. R., Crowe, S. M., & Jaworowski, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009643 · Cited by 20
Shankar, E. M., Vignesh, R., Murugavel, K. G., Balakrishnan, P., Sekar, R., Lloyd, C., Solomon, S., & Kumarasamy, N. (2007) · AIDS Research and Therapy · doi:10.1186/1742-6405-4-29 · Cited by 20
Impacts of HIV Cure Interventions on Viral Reservoirs in Tissues
Denton, P. W., Søgaard, O. S., & Tolstrup, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01956 · Cited by 19
Editing out HIV: application of gene editing technology to achieve functional cure
Xun, J., Zhang, X., Guo, S., Lu, H., & Chen, J. (2021) · Retrovirology · doi:10.1186/s12977-021-00581-1 · Cited by 22
Rocha, C. S., Alexander, K. L., Herrera, C., Weber, M. G., Grishina, I., Hirao, L. A., Kramer, D. J., Arredondo, J., Mende, A., Crakes, K. R., et al. (2025) · Mucosal Immunology · doi:10.1016/j.mucimm.2025.01.011 · Cited by 18
Self-citationMucosal Immunity in HIV/SIV Infection: T Cells, B Cells and Beyond
Shacklett, B. L. (2018) · Current Immunology Reviews · doi:10.2174/1573395514666180528081204 · Cited by 21
The pathogenesis of HIV infection: stupid may not be so dumb after all
Smith, S. M. (2006) · Retrovirology · doi:10.1186/1742-4690-3-60 · Cited by 19
Zhou, Y., Shen, L., Yang, H., & Siliciano, R. F. (2008) · Journal of Virology · doi:10.1128/jvi.00773-08 · Cited by 19
Immune Modulators of HIV Infection: The Role of Reactive Oxygen Species
Salmen, S., & Berrueta, L. (2012) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000121 · Cited by 19
Verhoeven, D. E., Sankaran, S., & Dandekar, S. (2007) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2007.00239.x · Cited by 19
Self-citationAdaptation of HIV-1 Depends on the Host-Cell Environment
van Opijnen, T., de Ronde, A., Boerlijst, M. C., & Berkhout, B. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000271 · Cited by 19
Prime-boost immunization strategies against HIV-1
Bråve, A. (2007) · Figshare · Cited by 19
George, J., Cofano, E. B., Lybarger, E. A., Louder, M. K., Lafont, B. A. P., Mascola, J. R., Robert-Guroff, M., & Mattapallil, J. J. (2010) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2010.0251 · Cited by 18
BenMarzouk‐Hidalgo, O. J., Torres-Cornejo, A., Gutiérrez‐Valencia, A., Ruiz-Valderas, R., Viciana, P., & López-Cortés, L. F. (2015) · Medicine · doi:10.1097/md.0000000000000781 · Cited by 18
Integrin α4β7 in HIV-1 infection: A critical review
Liu, Q., & Lusso, P. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mr0120-208r · Cited by 18
Chakrabarti, A. K., Caruso, L., Ding, M., Shen, C., Buchanan, W., Gupta, P., Rinaldo, C. R., & Chen, Y. (2009) · AIDS Research and Therapy · doi:10.1186/1742-6405-6-20 · Cited by 18
Estimating the Infectivity of CCR5-Tropic Simian Immunodeficiency Virus SIV mac251 in the Gut
Wilson, D. P., Mattapallil, J. J., Lay, M. D. H., Zhang, L., Roederer, M., & Davenport, M. P. (2007) · Journal of Virology · doi:10.1128/jvi.01771-06 · Cited by 18
HIV-1 Infection and the Aging of the Immune System: Facts, Similarities and Perspectives
Biasi, S. D., Pinti, M., Nasi, M., Gibellini, L., Bertoncelli, L., Manzini, S., Mussini, C., & Cossarizza, A. (2011) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2011.06.001 · Cited by 17
Immune‐Based Therapy for HIV Infection: Are Acute and Chronic HIV Infection Different Diseases?
Hunt, P. W., & Deeks, S. G. (2006) · The Journal of Infectious Diseases · doi:10.1086/509627 · Cited by 17
Weber, M. G., Walters-Laird, C. J., Kol, A., Rocha, C. S., Hirao, L. A., Mende, A., Balan, B., Arredondo, J., Elizaldi, S. R., Iyer, S. S., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.149033 · Cited by 17
Self-citationLim, H., Kim, K.-C., Son, J., Shin, Y., Yoon, C., Kang, C., & Choi, B. (2016) · Virus Research · doi:10.1016/j.virusres.2016.09.015 · Cited by 17
Zaunders, J. J., Danta, M., Bailey, M., Mak, G., Marks, K., Seddiki, N., Xu, Y., Templeton, D. J., Cooper, D. A., Boyd, M. A., et al. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00438 · Cited by 17
Grover, S., Mehta, P., Wang, Q., Bhatia, R. K., Bvochora-Nsingo, M. F., Davey, S. R., Iyengar, M., Shah, S., Shin, S. S., & Zetola, N. M. (2020) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002420 · Cited by 17
Papasavvas, E., Sun, J., Luo, Q., Moore, E. C., Thiel, B. D., MacGregor, R. R., Minty, A. J., Mounzer, K., Kostman, J. R., & Montaner, L. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5532 · Cited by 17
Chapter 9 HIV Induced AIDS and Related Cancers
Cadogan, M., & Dalgleish, A. G. (2008) · Advances in cancer research · doi:10.1016/s0065-230x(08)00409-0 · Cited by 17
HIV and the gut: implications for HIV persistence, immune dysfunction and cure strategies
Lau, J. S. Y., Lewin, S. R., & Telwatte, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1650852 · Cited by 19
Denton, P. W., Søgaard, O. S., & Tolstrup, M. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0807-y · Cited by 17
Jasinska, A. J., Apetrei, C., & Pandrea, I. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1060985 · Cited by 20
Severe intestinal barrier damage in HIV-infected immunological non-responders
Guo, X., Guo, Y., Wang, Z.-R., Jiao, Y., Hu, Y., Fan, L.-N., Cheng, R.-Q., Qu, M., Zhang, C., Song, J., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20790 · Cited by 16
Vesterbacka, J., Barqasho, B., Häggblom, A., & Nowak, P. (2015) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2014.0366 · Cited by 17
Metadata
- Authors
- Guadalupe, M., Reay, E., Sankaran, S., Prindiville, T., Flamm, J., McNeil, A., & Dandekar, S.
- Affiliations
- University of California, Davis (US)
- Departments of Medical Microbiology & Immunology
- The Permanente Medical Group Inc.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2003-11
- Volume
- 77
- Issue
- 21
- Pages
- 11708-11717
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC229357
- OpenAlex
- W2076120354
- Cited by
- 866
- References
- 24
- Citations by year
- 2026: 13 · 2025: 7 · 2024: 11 · 2023: 14 · 2022: 23 · 2021: 27 · 2020: 21 · 2019: 26 · 2018: 26 · 2017: 32 · 2016: 42 · 2015: 45 · 2014: 48 · 2013: 62 · 2012: 60
- FWCI
- 7.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 61297, R01DK061297)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
- Keywords
- HIV-1 infection, CD4+ T cell depletion, gut-associated lymphoid tissue, highly active antiretroviral therapy, CD4+ T cell recovery, jejunal biopsy, lymphocyte homing, nonprogressors, gene expression profiling, early treatment initiation
- MeSH terms
- Adult, Cell Movement, Chronic Disease, Female, Flow Cytometry, Humans, Immunohistochemistry, Jejunum, Lymphocyte Activation, Lymphoid Tissue, Male, Middle Aged, Time Factors, CD4-Positive T-Lymphocytes, HIV-1, HIV Infections, CD8-Positive T-Lymphocytes, CD4 Lymphocyte Count, Antiretroviral Therapy, Highly Active
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review